VIDA VENTURES II-A, LLC
SEC CIK 1781930 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AKTS | Aktis Oncology, Inc. | 10% | 134.8K | $15.03M | — | 2 | 2026-01-12 | 2026-01-12 |
Most active insiders at AKTS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | NODELMAN OLEG | Dir | $40.00M | — |
| 2 | MPM ONCOLOGY INNOVATIONS FUND LP | 10% | $20.03M | — |
| 3 | GADICKE ANSBERT | 10% | $20.03M | — |
| 4 | VIDA VENTURES II-A, LLC | 10% | $15.03M | — |
| 5 | Kim Helen Susan | Dir, 10% | $15.03M | — |
| 6 | Foley Todd | Dir, 10% | $4.19M | — |
| 7 | Czibere Akos | Chief Medical Off | — | $1.65M |
| 8 | Ron-Bigger Shulamit | COO | — | $1.39M |
| 9 | Herrmann Ken | Dir | — | $196.5K |
| 10 | Segal Lloyd Mitchell | Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-01-12 | 2026-01-12 | AKTS | Aktis Oncology, Inc. | VIDA VENTURES II-A, LLC | 10% | C - Cnv Deriv | — | +4.99M | 134.8K | New | — |
| DMI | 2026-01-12 | 2026-01-12 | AKTS | Aktis Oncology, Inc. | VIDA VENTURES II-A, LLC | 10% | P - Purchase | $18.00 | +835.0K | 5.67M | +17% | +$15.03M |
Purchase Sale Sale after option exercise All abbreviations